Patient Decision Aid for Antidepressant Use in Pregnancy
Patient Decision Aid (PDA) for Antidepressant Use In Pregnancy: a Pilot RCT
3 other identifiers
interventional
51
1 country
1
Brief Summary
The proposed study is a pilot randomized controlled trial (RCT) of an electronic patient decision aid (PDA) for antidepressant use in pregnancy. The overall aim of this pilot RCT is to establish the feasibility of future large international RCT of the PDA's effectiveness.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable depression
Started Jun 2015
Typical duration for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2015
CompletedFirst Submitted
Initial submission to the registry
June 22, 2015
CompletedFirst Posted
Study publicly available on registry
July 8, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2017
CompletedOctober 27, 2021
September 1, 2016
1.8 years
June 22, 2015
October 20, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Feasibility, measured by 'Recruitment Rate'
Up to one year from when the study starts enrolling participants
Secondary Outcomes (11)
Depression, measured by the Edinburgh Postnatal Depression Scale
(a) Baseline (pre-randomization) and (b) 4 Weeks post-randomization and (c) 12 weeks postpartum (for participants who enrolled while pregnant) OR 6 months post-randomization (for women who enrolled while planning a pregnancy)
Anxiety, measured by the Spielburg State-Trait Anxiety Inventory
(a) Baseline (pre-randomization) and (b) 4 Weeks post-randomization and (c) 12 weeks postpartum (for participants who enrolled while pregnant) OR 6 months post-randomization (for women who enrolled while planning a pregnancy)
Decisional conflict, measured by the Decisional Conflict Scale
Baseline (pre-randomization) and 4 Weeks post-randomization
Knowledge about antidepressant treatment in pregnancy
Baseline (pre-randomization) and 4 Weeks post-randomization
Intervention acceptability to patients, measured by the PDA Acceptability Questionnaire
4 Weeks post-randomization]
- +6 more secondary outcomes
Study Arms (2)
Standard Resource Sheet
PLACEBO COMPARATORWomen allocated to the control intervention will login to the study website and receive a printable PDF containing references to standard published information on antidepressant use in pregnancy. This ensures women have access to accurate information on the benefits and risks of antidepressant medication in pregnancy (even though they will not receive the PDA).
Electronic Patient Decision Aid
ACTIVE COMPARATORThe electronic Patient Decision Aid (PDA) is an interactive website with 3 main sections: 1. Evidence-based information on (a) depression in pregnancy, (b) each treatment option and procedure; 2. (a) Evidence-based information on the risks and benefits of both untreated depression and antidepressant treatment, (b) exercises to help women determine which risks and benefits are most important to them; and 3. A summary section that outlines the information reviewed and which benefits and risks they deemed most important. At the end of the PDA, women allocated to this intervention will ALSO receive the standard resource sheet which is being used as the placebo comparator.
Interventions
Women allocated to the control intervention will login to the study website and receive a printable PDF containing references to standard published information on antidepressant use in pregnancy. This ensures women have access to accurate information on the benefits and risks of antidepressant medication in pregnancy (even though they will not receive the PDA).
The electronic Patient Decision Aid (PDA) is an interactive website with 3 main sections: 1. Evidence-based information on (a) depression in pregnancy, (b) each treatment option and procedure; 2. (a) Evidence-based information on the risks and benefits of both untreated depression and antidepressant treatment, (b) exercises to help women determine which risks and benefits are most important to them; and 3. A summary section that outlines the information reviewed and which benefits and risks they deemed most important. At the end of the PDA, women allocated to this intervention will ALSO receive the standard resource sheet which is being used as the placebo comparator.
Eligibility Criteria
You may qualify if:
- Are aged over 18
- Are planning a pregnancy or are \<30 weeks pregnant at enrolment
- Have been offered to start or continue an antidepressant as treatment for depression by their clinician a
- Have moderate-to-high decisional conflict (score of \>25 on the Decisional Conflict Scale)
You may not qualify if:
- Have had alcohol or drug abuse or dependence in the previous 12 months
- Have active suicidal ideation or psychosis
- Are incapable of consenting to participation
- Have any major obstetric complications or foetal cardiac anomaly in the current or in a past pregnancy,
- Are visually impaired
- Do not have sufficient English language proficiency to use the PDA.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- King's College Londonlead
- University of Torontocollaborator
Study Sites (1)
South London and Maudsley NHS Foundation Trust
London, SE5 8AF, United Kingdom
Related Publications (1)
Khalifeh H, Molyneaux E, Brauer R, Vigod S, Howard LM. Patient decision aids for antidepressant use in pregnancy: a pilot randomised controlled trial in the UK. BJGP Open. 2019 Dec 10;3(4):bjgpopen19X101666. doi: 10.3399/bjgpopen19X101666. Online ahead of print.
PMID: 31822489RESULT
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Louise M Howard, PhD
Section of Women's Mental Health, King's College London
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 22, 2015
First Posted
July 8, 2015
Study Start
June 1, 2015
Primary Completion
March 1, 2017
Study Completion
November 1, 2017
Last Updated
October 27, 2021
Record last verified: 2016-09